SPY-X: Fluorescence Lymphangiography in Melanoma and Breast Cancer

Phase 3, open-label, single-arm trial of indocyanine green in melanoma and breast cancer, sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Number of Participants Where the First, Second and Third Sentinel Nodes Localized With the Use of Fluorescence Imaging Alone up to 1 hour. Started Oct 2017; status: completed.